Purpose: A cationic peptide, Mel4, bound to contact lenses has completed a phase III clinical trial and had the ability to prevent >60% of infiltrative events (1). However, the lenses lost their activity after six nights of wear, probably due to digestion of Mel4 by tear enzymes (2). Peptoids based upon N-substituted glycine as a backbone are protease-resistant (3). This study evaluated the activity of peptoids covalently immobilized on etafilcon A contact lenses to inhibit binding of Pseudomonas aeruginosa.
Methods: The minimum inhibitory concentration (MIC) of antimicrobial peptide and peptoids were determined by microbroth dilution method against P. aeruginosa 6294, polymyxin-resistant P. aeruginosa 123, and beta-lactamase resistant ATCC 19660. The cationic peptide melimine and peptoids TM5 and TM18 were covalently bound to etafilcon A via the EDC chemical reaction (4). Bacterial adhesion was performed by adding 5x106 CFU mL-1 of each strain to contact lenses and incubating for 18 hours at 37°C. The toxicity of the compounds was measured by exposing coated contact lenses to human corneal epithelial cells.
Results: The MIC of compounds TM5 and TM18 against three strains of P. aeruginosa were 18-37 µM and 12-25 µM, respectively. The adhesion of all strains of P. aeruginosa to lenses was 5.6±0.21 CFU mL-1 cells/lens. Bound melimine resulted in 3.1±0.07 log10 reduction in bacterial adhesion. TM5-bound lenses were non-toxic, and TM18-bound lenses produced 30% toxicity to corneal epithelial cells.
Conclusion: The peptoids TM5 and TM18 both had potent activity against multidrug-resistant strains of P. aeruginosa, retained their activity when covalently bound to etafilcon A lenses, and TM5 showed no toxicity, while TM18 showed 30% toxicity to corneal epithelial cells. This indicates that the peptoid TM5 may be an excellent alternative for potential development within antimicrobial lenses.